CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a novel method using nucleic acid binders to create complex molecules for drug discovery, particularly targeting multidrug-resistant bacteria. The approach aims to simplify the synthesis of new antibiotics and improve bioimaging technologies.
The pharmaceutical sector has a huge demand for new active compounds including natural products to fill the drug pipelines and to stop the global decline in novel approved active pharmaceutical ingredients.
Therefore, developing new tools to fabricate complex molecular structures in a fast and reliable way is paramount.
This holds especially true for the field of antibiotics.
Multidrug resistant (MDR) pathogens evolve at a terrifying rate and confer resistance to all presently available antibact…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Groningen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
